Prevalence of hypertensive diseases and treated hypertensive patients in Japan: A nationwide administrative claims database study

被引:0
作者
Takashi Waki
Katsuyuki Miura
Sachiko Tanaka-Mizuno
Yusuke Ohya
Koichi Node
Hiroshi Itoh
Hiromi Rakugi
Jumpei Sato
Kazuo Goda
Masaru Kitsuregawa
Tomoki Ishikawa
Naohiro Mitsutake
机构
[1] Shiga University of Medical Science,Department of Public Health
[2] Otsu,NCD Epidemiology Research Center (NERC)
[3] Shiga University of Medical Science,Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health
[4] Otsu,Department of Cardiovascular Medicine, Nephrology and Neurology
[5] Kyoto University,Department of Cardiovascular Medicine
[6] Kyoto,Department of Endocrinology, Metabolism and Nephrology
[7] University of the Ryukyus,Department of Geriatric and General Medicine
[8] Graduate School of Medicine,Institute of Industrial Science
[9] Nakagami,undefined
[10] Saga University,undefined
[11] Saga,undefined
[12] Keio University School of Medicine,undefined
[13] Shinjuku,undefined
[14] The Japanese Society of Hypertension,undefined
[15] Bunkyo,undefined
[16] Osaka University Graduate School of Medicine,undefined
[17] Suita,undefined
[18] The University of Tokyo,undefined
[19] Meguro,undefined
[20] Institute for Health Economics and Policy,undefined
[21] Minato,undefined
来源
Hypertension Research | 2022年 / 45卷
关键词
National database; Geographical distribution; Hypertensive disease; Exhaustive study; Administrative claims data;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated the prevalence of hypertensive patients and treated hypertensive patients using a Japanese nationwide administrative claims database. We analyzed national database data from 2014, including all claims data, provided by the Ministry of Health, Labour and Welfare of Japan. Hypertensive diseases were identified using Japanese standardized disease codes. Among hypertensive patients, treated hypertensive patients were defined by the prescription of any antihypertensive medication, identified using national health insurance price listing codes. We calculated and compared the number and age-adjusted prevalence of hypertensive patients and treated hypertensive patients by prefecture and the proportion of these patients by the size of medical facilities. In 2014, approximately 27 million Japanese people were identified as hypertensive, among which 89.6% were treated. The age-adjusted prevalence of hypertensive patients (per 100,000 persons) among women and men was 21,414 and 21,084, respectively. The age-adjusted prevalence of treated hypertensive patients (per 100,000 persons) among women and men was 19,118 and 18,974, respectively. While the prevalence of hypertensive and treated hypertensive patients varied geographically, the prevalence remained similar between the sexes. Approximately 59% of hypertensive patients visited clinics (0 to 19 beds) in Japan. In Japan, 27 million people were diagnosed with hypertensive diseases, and approximately 90% of these patients were treated with any antihypertensive medication in 2014. The distribution of hypertensive patients varied geographically throughout Japan.
引用
收藏
页码:1123 / 1133
页数:10
相关论文
共 117 条
[21]  
Chow CK(1988)Results for 24 h urinary sodium and potassium excretion. Intersalt Cooperative Research Group BMJ. (Clin Res ed) 297 319-28
[22]  
Teo KK(2018)Current use of antihypertensive drugs in Japanese patients with hypertension: Analysis by age group Geriatr Gerontol Int. 18 899-906
[23]  
Rangarajan S(2019)Lifetime risk of stroke and coronary heart disease deaths according to blood pressure level: EPOCH-JAPAN (Evidence for Cardiovascular Prevention From Observational Cohorts in Japan) Hypertension 73 52-59
[24]  
Islam S(2016)Hypertension and lifetime risk of stroke J Hypertens. 34 116-22
[25]  
Gupta R(2016)Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries Circulation 134 441-50
[26]  
Avezum A(2021)Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants Lancet. 398 957-80
[27]  
Umemura S(undefined)undefined undefined undefined undefined-undefined
[28]  
Arima H(undefined)undefined undefined undefined undefined-undefined
[29]  
Arima S(undefined)undefined undefined undefined undefined-undefined
[30]  
Asayama K(undefined)undefined undefined undefined undefined-undefined